acrisorcin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
5103 7527-91-5

Description:

MoleculeDescription

Synonyms:

  • acrisorcin
  • akrinol
A topical anti-fungal agent. Acrisorcin is comprised of two active ingredients, 9-aminoacridine and 4-hexylresorcinol, but its clinical use has been discontinued.
  • Molecular weight: 388.51
  • Formula: C25H28N2O2
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 38.91
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
None FDA SCHERING

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

None

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Pityriasis versicolor indication 56454009 DOID:9060




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
2U918O4BEV UNII
D02759 KEGG_DRUG
C0002503 UMLSCUI
CHEMBL1201038 ChEMBL_ID
24144 PUBCHEM_CID
1451 INN_ID
89729 RXNORM
002905 NDDF
34113002 SNOMEDCT_US

Pharmaceutical products:

None